查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1771463

全球神经病学临床试验市场：市场规模、份额、趋势分析（按阶段、按研究设计、按适应症、按价值链、按地区）、按细分市场预测（2025-2030 年）

Neurology Clinical Trials Market Size, Share & Trends Analysis Report By Phase, By Study Design, By Indication, By Indication by Study Design, By Indication by Phase, By Value Chain, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

神经病学临床试验市场的成长与趋势：

根据 Grand View Research, Inc. 的最新报告，全球神经病学临床试验市场规模预计到 2030 年将达到 84.2 亿美元，2025 年至 2030 年的复合年增长率为 6.39%。

这主要是因为大型製药公司正在进行创新的神经科学临床试验、政府对美国神经疾病和中风研究所 (NINDS) 的津贴不断增加、以及全球神经疾病的盛行率很高。

神经科学领域持续获得稳健的投资。例如，2022年11月，NRG Therapeutics在A轮融资中筹集了1,830万美元，用于开发粒线体疗法，以治疗肌萎缩侧索硬化症（ALS）和帕金森氏症等神经退化性疾病。预计未来类似的措施将持续推行，推动市场成长。

全球有相当多的人患有神经系统疾病。例如，根据帕金森氏症基金会的统计数据，每年有6万名美国被诊断出患有帕金森氏症，全球有超过1,000万人患有这种疾病。关于癫痫，世界卫生组织指出，全球有超过6,500万人患有癫痫。这种疾病在中低收入国家最为常见，占癫痫患者的80.0%。神经系统疾病的高盛行率预计将推动临床试验的需求并支持市场。

神经病学被认为是进行临床试验的主要领域之一。根据《製药研发年度回顾》，2021年，神经病学临床试验是临床试验主要进行的第三大领域。根据《製药研发年度回顾》报道，神经病学领域共有超过2,900种药物正在进行临床实验，而2022年则有超过3,200种药物正在进行临床实验。预计神经病学领域启动临床试验的药物数量的增加将在疫情后支撑市场。

神经病学临床试验市场：分析概述

  • 根据阶段，II 期将占据市场主导地位，到 2024 年将占据 42.14% 的最大收入份额。大多数神经病学临床试验目前处于第 2 阶段，这为该领域的市场提供了支持。
  • 根据试验设计，介入部分在 2024 年占据了最大的市场收入份额。按照这种试验设计进行的大量神经病学临床试验正在推动该部分的市场成长。
  • 根据适应症，亨廷顿舞蹈症领域预计在预测期内将出现显着的复合年增长率，这主要归因于全球对亨廷顿舞蹈症药物的需求量很大。
  • 北美将主导市场，到 2024 年将占据 46.96% 的收入份额。神经系统疾病盛行率的上升以及许多公司参与临床试验正在推动该地区市场的发展，这是市场占有率高的主要原因。

目录

第一章 分析方法与范围

第二章执行摘要

第三章神经病学临床试验市场：变数、趋势和范围

  • 市场联动展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制分析
    • 市场机会
    • 市场挑战
  • 技术状况
  • 定价模式分析
  • 研发成本分析（2018-2024）
  • 临床试验数量分析（2024年）
  • 市场分析工具
    • 波特五力分析
    • PESTEL 与 SWOT 分析
    • COVID-19影响分析

第四章神经病学临床试验市场：各阶段的估计和趋势分析

  • 神经病学临床试验市场：细分仪表板（按阶段划分）
  • 神经病学临床试验市场：依阶段进行变异分析
  • 按阶段（2018-2030）
  • 第一阶段
  • 第二阶段
  • 第三阶段
  • 第四阶段

第五章神经病学临床试验市场：依研究设计进行的估计与趋势分析

  • 神经病学临床试验市场：细分仪表板（依研究设计）
  • 神经病学临床试验市场：依研究设计进行的变异分析
  • 依测试设计（2018-2030）
  • 侵入性
  • 观察性
  • 扩展访问

第六章神经病学临床试验市场：按适应症分類的估计和趋势

  • 神经病学临床试验市场：细分仪表板（按适应症划分）
  • 神经病学临床试验市场：依适应症进行变异分析
  • 依适应症（2018-2030）
  • 神经病学临床试验市场（按适应症）：细分仪表板
  • 神经病学临床试验市场（按适应症）：变异分析
  • 依适应症（2018-2030）
  • 阿兹海默症
  • 忧郁症（MDD）
  • 帕金森氏症（PD）
  • 癫痫
  • 中风
  • 创伤性脑损伤（TBI）
  • 肌萎缩侧索硬化症（ALS）
  • 亨丁顿舞蹈症
  • 肌肉再生
  • 其他的

第七章神经病学临床试验市场：按研究设计和适应症进行的估计和趋势分析

  • 神经病学临床试验市场（按研究设计和适应症）：细分仪表板
  • 神经病学临床试验市场（依研究设计与适应症）：变异分析
  • 依测试设计（2018-2030）
  • 阿兹海默症
    • 阿兹海默症干预
    • 阿兹海默症- 观察
    • 阿兹海默症扩大可及性
  • 忧郁症（MDD）
    • 忧郁症（MDD）-干预
    • 忧郁症（MDD）-观察
    • 忧郁症（MDD）- 扩展访问
  • 帕金森氏症（PD）
    • 帕金森氏症（PD）干预
    • 帕金森氏症（PD）-观察
    • 帕金森氏症 (PD) - 扩展访问
  • 癫痫
    • 癫痫/干预
    • 癫痫/观察
    • 癫痫/扩大准入
  • 中风
    • 中风/干预
    • 行程/观察
    • 中风/扩大访问
  • 创伤性脑损伤（TBI）
    • 创伤性脑损伤 (TBI) 干预
    • 创伤性脑损伤 (TBI) - 观察
    • 创伤性脑损伤 (TBI) 扩展获取途径
  • 肌萎缩侧索硬化症（ALS）
    • 肌萎缩侧索硬化症（ALS）-干预
    • 肌萎缩侧索硬化症（ALS）－观察性研究
    • 肌萎缩侧索硬化症 (ALS) - 扩展访问
  • 亨丁顿舞蹈症
    • 亨廷顿舞蹈症干预
    • 亨廷顿舞蹈症 - 观察
    • 亨丁顿舞蹈症扩大获取途径
  • 肌肉再生
    • 肌肉再生/干预
    • 肌肉再生与观察
    • 肌肉再生和扩张途径
  • 其他的
    • 其他干预措施
    • 其他观察
    • 其他扩展访问

第 8 章神经病学临床试验市场：按阶段和适应症的估计和趋势

  • 神经病学临床试验市场：按阶段和适应症分類的细分仪表板
  • 神经病学临床试验市场：按阶段和适应症进行的变化分析
  • 按阶段（2018-2030）
  • 阿兹海默症
    • 阿兹海默症I 期
    • 阿兹海默症II 期
    • 阿兹海默症III 期
    • 阿兹海默症IV 期
  • 忧郁症（MDD）
    • 忧郁症（MDD）第一阶段
    • 忧郁症（MDD）III期
    • 忧郁症（MDD）III期
    • 忧郁症（MDD）IV期
  • 帕金森氏症（PD）
    • 帕金森氏症（PD）I期
    • 帕金森氏症（PD）II期
    • 帕金森氏症（PD）III期
    • 帕金森氏症（PD）IV期
  • 癫痫
    • 癫痫 I 期
    • 癫痫 II 期
    • 癫痫 III 期
    • 癫痫IV期
  • 中风
    • 中风 I 期
    • 中风 II 期
    • 中风 III 期
    • 中风IV期
  • 创伤性脑损伤（TBI）
    • 创伤性脑损伤 (TBI) 第一阶段
    • 创伤性脑损伤（TBI）II期
    • 创伤性脑损伤 (TBI) III 期
    • 创伤性脑损伤 (TBI) IV 期
  • 肌萎缩侧索硬化症（ALS）
    • 肌萎缩侧索硬化症（ALS）I期
    • 肌萎缩侧索硬化症（ALS）II期
    • 肌萎缩侧索硬化症（ALS）III期
    • 肌萎缩侧索硬化症（ALS）IV期
  • 亨丁顿舞蹈症
    • 亨廷顿氏舞蹈症 I 期
    • 亨廷顿氏舞蹈症 II 期
    • 亨丁顿舞蹈症 III 期
    • 亨廷顿氏舞蹈症 IV 期
  • 肌肉再生
    • 肌肉再生第一阶段
    • 肌肉再生第二阶段
    • 肌肉再生第三阶段
    • 肌肉再生第四阶段
  • 其他的
    • 其他/第一阶段
    • 其他/二期
    • 其他/三期
    • 其他/第四阶段

第九章神经病学临床试验市场：按价值链的估计和趋势分析

  • 神经病学临床试验市场：细分仪表板、按价值链
  • 神经病学临床试验市场：依价值链进行变异分析
  • 按价值链划分（2018-2030年）
  • 内部
  • CRO
  • 临床实验试验地点/临床设施

第 10 章神经病学临床试验市场：区域估计和趋势分析

  • 市场仪表板：按地区
  • 各地区市场占有率（2024 年及 2030 年）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 泰国
    • 韩国
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特
Product Code: GVR-4-68038-352-2

Neurology Clinical Trials Market Growth & Trends:

The global neurology clinical trials market size is estimated to reach USD 8.42 billion by 2030, registering a CAGR of 6.39% from 2025 to 2030, according to a new report by Grand View Research, Inc. This is largely attributed to big pharma companies conducting innovative trials in neurology, increased government funding from the National Institute of Neurological Disorders and Stroke (NINDS), and the high prevalence of neurological disorders worldwide.

Neuroscience continues to receive a healthy investment. For instance, in November 2022, NRG Therapeutics raised Series A funding of USD 18.3 million for the development of mitochondrial therapeutics to treat neurodegenerative ailments such as amyotrophic lateral sclerosis (ALS) and Parkinson's disease. The adoption of similar initiatives in the future is expected to support market growth.

A significant number of people worldwide suffer from neurological disorders. For instance, as per the statistics from Parkinson's Foundation, every year 60,000 Americans are diagnosed with PD and more than 10 million people are living with the disease around the world. In terms of Epilepsy, the WHO states that more than 65 million people worldwide are affected by it. The disease is most prevalent in low- and middle-income countries, which account for 80.0% of epilepsy cases. A high prevalence of neurological disorders is expected to boost demand for clinical trials and thus support the market.

Neurology is considered as one of the major areas where clinical trials are conducted. As per the Pharma R&D Annual Review, in 2021, Neurology trials were the third area where clinical trials were majorly focused. The Pharma R&D Annual Review stated that for neurology above 2,900 drugs were under trial and in the year 2022 the number of drugs for clinical studies in the area of neurology accounted for more than 3,200 active drugs. An increasing number of drugs entering clinical trials in the area of neurology are expected to support the market in the post-pandemic period.

Neurology Clinical Trials Market Report Highlights:

  • By phase, the phase II segment dominated the market and accounted for a maximum revenue share of 42.14% in 2024. A majority number of neurology clinical trials are currently in Phase 2, this is supporting the segment market.
  • By study design, the interventional segment held the largest market revenue share of in 2024. A high number of neurology clinical trials conducted through this study design type is promoting the growth of the segment market.
  • By indication, the Huntington's disease segment is anticipated to register the significant CAGR over the forecast period. This is largely due to the fact that there is a high demand for the medicines used for Huntington's disease worldwide as there are no medications available for treating this disease.
  • North America dominated the market and accounted for a revenue share of 46.96% in 2024. The rising prevalence of neurological disorders and the presence of a large number of players in clinical trials drive the market in the region. These are some of the key reasons for the high market share.

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Study Design
    • 1.2.2. Indication
    • 1.2.3. Indication by Study Design
    • 1.2.4. Indication by Phase
    • 1.2.5. Value Chain
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Parent Market Analysis
  • 1.8. List Of Secondary Sources
  • 1.9. List Of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Neurology Clinical Trials Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing prevalence of neurological diseases such as Alzheimer disease, epilepsy, and stroke
      • 3.2.1.2. Growing adoption of novel technologies in clinical research
      • 3.2.1.3. Substantial number of CROs providing neurology clinical research services
      • 3.2.1.4. Increasing funding for neurological studies by public organizations
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost associated with neurology clinical studies
      • 3.2.2.2. High failure rate coupled with patient dropout issues associated with neurological clinical trials
    • 3.2.3. Market Challenges
    • 3.2.4. Market Opportunities
  • 3.3. Technology Landscape
  • 3.4. Pricing Model Analysis
  • 3.5. R&D Spending Analysis (2018-2024)
  • 3.6. Clinical Trial Volume Analysis, 2024
  • 3.7. Market Analysis Tools
    • 3.7.1. Porter's Five Force Analysis
    • 3.7.2. PESTEL by SWOT Analysis
    • 3.7.3. COVID-19 Impact Analysis

Chapter 4. Neurology Clinical Trials Market: Phase Estimates & Trend Analysis

  • 4.1. Neurology Clinical Trials Market, By Phase: Segment Dashboard
  • 4.2. Neurology Clinical Trials Market, By Phase: Movement Analysis
  • 4.3. Neurology Clinical Trials Market Estimates & Forecasts, By Phase, 2018 - 2030 (USD Million)
  • 4.4. Phase I
    • 4.4.1. Phase I Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Phase II
    • 4.5.1. Phase II Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Phase III
    • 4.6.1. Phase III Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Phase IV
    • 4.7.1. Phase IV Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Neurology Clinical Trials Market: Study Design Estimates & Trend Analysis

  • 5.1. Neurology Clinical Trials Market, By Study Design: Segment Dashboard
  • 5.2. Neurology Clinical Trials Market, By Study Design: Movement Analysis
  • 5.3. Neurology Clinical Trials Market Estimates & Forecasts, By Study Design, 2018 - 2030 (USD Million)
  • 5.4. Interventional
    • 5.4.1. Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Observational
    • 5.5.1. Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Expanded Access
    • 5.6.1. Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Neurology Clinical Trials Market: Indication Estimates & Trend Analysis

  • 6.1. Neurology Clinical Trials Market, By Indication: Segment Dashboard
  • 6.2. Neurology Clinical Trials Market, By Indication: Movement Analysis
  • 6.3. Neurology Clinical Trials Market Estimates & Forecasts, By Indication, 2018 - 2030 (USD Million)
  • 6.4. Alzheimer's Disease
    • 6.4.1. Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Depression (MDD)
    • 6.5.1. Depression (MDD) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Parkinson's Disease (PD)
    • 6.6.1. Parkinson's Disease (PD) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Epilepsy
    • 6.7.1. Epilepsy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. Stroke
    • 6.8.1. Stroke Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.9. Traumatic Brain Injury (TBI)
    • 6.9.1. Traumatic Brain Injury (TBI) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.10. Amyotrophic Lateral Sclerosis (ALS)
    • 6.10.1. Amyotrophic Lateral Sclerosis (ALS) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.11. Huntington's Disease
    • 6.11.1. Huntington's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.12. Muscle Regeneration
    • 6.12.1. Muscle Regeneration Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.13. Others
    • 6.13.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Neurology Clinical Trials Market: Indication by Study Design Estimates & Trend Analysis

  • 7.1. Neurology Clinical Trials Market, Indication by Study Design: Segment Dashboard
  • 7.2. Neurology Clinical Trials Market, Indication by Study Design: Movement Analysis
  • 7.3. Neurology Clinical Trials Market Estimates & Forecasts, Indication by Study Design, 2018 - 2030 (USD Million)
  • 7.4. Alzheimer's Disease
    • 7.4.1. Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. Alzheimer's Disease Interventional
      • 7.4.2.1. Alzheimer's Disease Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Alzheimer's Disease Observational
      • 7.4.3.1. Alzheimer's Disease Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Alzheimer's Disease Expanded Access
      • 7.4.4.1. Alzheimer's Disease Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Depression (MDD)
    • 7.5.1. Depression (MDD) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Depression (MDD) Interventional
      • 7.5.2.1. Depression (MDD) Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Depression (MDD) Observational
      • 7.5.3.1. Depression (MDD) Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. Depression (MDD) Expanded Access
      • 7.5.4.1. Depression (MDD) Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Parkinson's Disease (PD)
    • 7.6.1. Parkinson's Disease (PD) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Parkinson's Disease (PD) Interventional
      • 7.6.2.1. Parkinson's Disease (PD) Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. Parkinson's Disease (PD) Observational
      • 7.6.3.1. Parkinson's Disease (PD) Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. Parkinson's Disease (PD) Expanded Access
      • 7.6.4.1. Parkinson's Disease (PD) Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Epilepsy
    • 7.7.1. Epilepsy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. Epilepsy Interventional
      • 7.7.2.1. Epilepsy Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Epilepsy Observational
      • 7.7.3.1. Epilepsy Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.4. Epilepsy Expanded Access
      • 7.7.4.1. Epilepsy Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. Stroke
    • 7.8.1. Stroke Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.2. Stroke Interventional
      • 7.8.2.1. Stroke Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Stroke Observational
      • 7.8.3.1. Stroke Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. Stroke Expanded Access
      • 7.8.4.1. Stroke Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9. Traumatic Brain Injury (TBI)
    • 7.9.1. Traumatic Brain Injury (TBI) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.9.2. Traumatic Brain Injury (TBI) Interventional
      • 7.9.2.1. Traumatic Brain Injury (TBI) Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.9.3. Traumatic Brain Injury (TBI) Observational
      • 7.9.3.1. Traumatic Brain Injury (TBI) Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.9.4. Traumatic Brain Injury (TBI) Expanded Access
      • 7.9.4.1. Traumatic Brain Injury (TBI) Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.10. Amyotrophic Lateral Sclerosis (ALS)
    • 7.10.1. Amyotrophic Lateral Sclerosis (ALS) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.10.2. Amyotrophic Lateral Sclerosis (ALS) Interventional
      • 7.10.2.1. Amyotrophic Lateral Sclerosis (ALS) Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.10.3. Amyotrophic Lateral Sclerosis (ALS) Observational
      • 7.10.3.1. Amyotrophic Lateral Sclerosis (ALS) Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.10.4. Amyotrophic Lateral Sclerosis (ALS) Expanded Access
      • 7.10.4.1. Amyotrophic Lateral Sclerosis (ALS) Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.11. Huntington's Disease
    • 7.11.1. Huntington's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.11.2. Huntington's Disease Interventional
      • 7.11.2.1. Huntington's Disease Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.11.3. Huntington's Disease Observational
      • 7.11.3.1. Huntington's Disease Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.11.4. Huntington's Disease Expanded Access
      • 7.11.4.1. Huntington's Disease Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.12. Muscle Regeneration
    • 7.12.1. Muscle Regeneration Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.12.2. Muscle Regeneration Interventional
      • 7.12.2.1. Muscle Regeneration Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.12.3. Muscle Regeneration Observational
      • 7.12.3.1. Muscle Regeneration Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.12.4. Muscle Regeneration Expanded Access
      • 7.12.4.1. Muscle Regeneration Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.13. Others
    • 7.13.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.13.2. Others Interventional
      • 7.13.2.1. Others Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.13.3. Others Observational
      • 7.13.3.1. Others Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.13.4. Others Expanded Access
      • 7.13.4.1. Others Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Neurology Clinical Trials Market: Indication by Phase Estimates & Trend Analysis

  • 8.1. Neurology Clinical Trials Market, Indication by Phase: Segment Dashboard
  • 8.2. Neurology Clinical Trials Market, Indication by Phase: Movement Analysis
  • 8.3. Neurology Clinical Trials Market Estimates & Forecasts, Indication by Phase, 2018 - 2030 (USD Million)
  • 8.4. Alzheimer's Disease
    • 8.4.1. Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. Alzheimer's Disease Phase I
      • 8.4.2.1. Alzheimer's Disease Phase I Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. Alzheimer's Disease Phase II
      • 8.4.3.1. Alzheimer's Disease Phase II Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. Alzheimer's Disease Phase III
      • 8.4.4.1. Alzheimer's Disease Phase III Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.5. Alzheimer's Disease Phase IV
      • 8.4.5.1. Alzheimer's Disease Phase IV Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Depression (MDD)
    • 8.5.1. Depression (MDD) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. Depression (MDD) Phase I
      • 8.5.2.1. Depression (MDD) Phase I Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Depression (MDD) Phase II
      • 8.5.3.1. Depression (MDD) Phase II Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.4. Depression (MDD) Phase III
      • 8.5.4.1. Depression (MDD) Phase III Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.5. Depression (MDD) Phase IV
      • 8.5.5.1. Depression (MDD) Phase IV Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Parkinson's Disease (PD)
    • 8.6.1. Parkinson's Disease (PD) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. Parkinson's Disease (PD) Phase I
      • 8.6.2.1. Parkinson's Disease (PD) Phase I Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. Parkinson's Disease (PD) Phase II
      • 8.6.3.1. Parkinson's Disease (PD) Phase II Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. Parkinson's Disease (PD) Phase III
      • 8.6.4.1. Parkinson's Disease (PD) Phase III Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.5. Parkinson's Disease (PD) Phase IV
      • 8.6.5.1. Parkinson's Disease (PD) Phase IV Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7. Epilepsy
    • 8.7.1. Epilepsy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.2. Epilepsy Phase I
      • 8.7.2.1. Epilepsy Phase I Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.3. Epilepsy Phase II
      • 8.7.3.1. Epilepsy Phase II Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.4. Epilepsy Phase III
      • 8.7.4.1. Epilepsy Phase III Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.5. Epilepsy Phase IV
      • 8.7.5.1. Epilepsy Phase IV Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8. Stroke
    • 8.8.1. Stroke Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.2. Stroke Phase I
      • 8.8.2.1. Stroke Phase I Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.3. Stroke Phase II
      • 8.8.3.1. Stroke Phase II Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.4. Stroke Phase III
      • 8.8.4.1. Stroke Phase III Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.5. Stroke Phase IV
      • 8.8.5.1. Stroke Phase IV Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.9. Traumatic Brain Injury (TBI)
    • 8.9.1. Traumatic Brain Injury (TBI) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.9.2. Traumatic Brain Injury (TBI) Phase I
      • 8.9.2.1. Traumatic Brain Injury (TBI) Phase I Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.9.3. Traumatic Brain Injury (TBI) Phase II
      • 8.9.3.1. Traumatic Brain Injury (TBI) Phase II Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.9.4. Traumatic Brain Injury (TBI) Phase III
      • 8.9.4.1. Traumatic Brain Injury (TBI) Phase III Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.9.5. Traumatic Brain Injury (TBI) Phase IV
      • 8.9.5.1. Traumatic Brain Injury (TBI) Phase IV Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.10. Amyotrophic Lateral Sclerosis (ALS)
    • 8.10.1. Amyotrophic Lateral Sclerosis (ALS) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.10.2. Amyotrophic Lateral Sclerosis (ALS) Phase I
      • 8.10.2.1. Amyotrophic Lateral Sclerosis (ALS) Phase I Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.10.3. Amyotrophic Lateral Sclerosis (ALS) Phase II
      • 8.10.3.1. Amyotrophic Lateral Sclerosis (ALS) Phase II Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.10.4. Amyotrophic Lateral Sclerosis (ALS) Phase III
      • 8.10.4.1. Amyotrophic Lateral Sclerosis (ALS) Phase III Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.10.5. Amyotrophic Lateral Sclerosis (ALS) Phase IV
      • 8.10.5.1. Amyotrophic Lateral Sclerosis (ALS) Phase IV Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.11. Huntington's Disease
    • 8.11.1. Huntington's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.11.2. Huntington's Disease Phase I
      • 8.11.2.1. Huntington's Disease Phase I Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.11.3. Huntington's Disease Phase II
      • 8.11.3.1. Huntington's Disease Phase II Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.11.4. Huntington's Disease Phase III
      • 8.11.4.1. Huntington's Disease Phase III Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.11.5. Huntington's Disease Phase IV
      • 8.11.5.1. Huntington's Disease Phase IV Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.12. Muscle Regeneration
    • 8.12.1. Muscle Regeneration Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.12.2. Muscle Regeneration Phase I
      • 8.12.2.1. Muscle Regeneration Phase I Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.12.3. Muscle Regeneration Phase II
      • 8.12.3.1. Muscle Regeneration Phase II Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.12.4. Muscle Regeneration Phase III
      • 8.12.4.1. Muscle Regeneration Phase III Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.12.5. Muscle Regeneration Phase IV
      • 8.12.5.1. Muscle Regeneration Phase IV Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.13. Others
    • 8.13.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.13.2. Others Phase I
      • 8.13.2.1. Others Phase I Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.13.3. Others Phase II
      • 8.13.3.1. Others Phase II Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.13.4. Others Phase III
      • 8.13.4.1. Others Phase III Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.13.5. Others Phase IV
      • 8.13.5.1. Others Phase IV Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Neurology Clinical Trials Market: Value Chain Estimates & Trend Analysis

  • 9.1. Neurology Clinical Trials Market, By Value Chain: Segment Dashboard
  • 9.2. Neurology Clinical Trials Market, By Value Chain: Movement Analysis
  • 9.3. Neurology Clinical Trials Market Estimates & Forecasts, By Value Chain, 2018 - 2030 (USD Million)
  • 9.4. In-house
    • 9.4.1. In-house Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5. CROs
    • 9.5.1. CROs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.6. Investigator Sites/Clinical Sites
    • 9.6.1. Investigator Sites/Clinical Sites Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 10. Neurology Clinical Trials Market: Regional Estimates & Trend Analysis

  • 10.1. Regional Market Dashboard
  • 10.2. Regional Market Share Analysis, 2024 & 2030
  • 10.3. North America
    • 10.3.1. North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.3.2. U.S
      • 10.3.2.1. Key Country Dynamics
      • 10.3.2.2. Competitive Scenario
      • 10.3.2.3. Regulatory Framework
      • 10.3.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.3.3. Canada
      • 10.3.3.1. Key Country Dynamics
      • 10.3.3.2. Competitive Scenario
      • 10.3.3.3. Regulatory Framework
      • 10.3.3.4. Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.3.4. Mexico
      • 10.3.4.1. Key Country Dynamics
      • 10.3.4.2. Competitive Scenario
      • 10.3.4.3. Regulatory Framework
      • 10.3.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 10.4. Europe
    • 10.4.1. Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.4.2. UK
      • 10.4.2.1. Key Country Dynamics
      • 10.4.2.2. Competitive Scenario
      • 10.4.2.3. Regulatory Framework
      • 10.4.2.4. UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.4.3. Germany
      • 10.4.3.1. Key Country Dynamics
      • 10.4.3.2. Competitive Scenario
      • 10.4.3.3. Regulatory Framework
      • 10.4.3.4. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.4.4. France
      • 10.4.4.1. Key Country Dynamics
      • 10.4.4.2. Competitive Scenario
      • 10.4.4.3. Regulatory Framework
      • 10.4.4.4. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.4.5. Italy
      • 10.4.5.1. Key Country Dynamics
      • 10.4.5.2. Competitive Scenario
      • 10.4.5.3. Regulatory Framework
      • 10.4.5.4. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.4.6. Spain
      • 10.4.6.1. Key Country Dynamics
      • 10.4.6.2. Competitive Scenario
      • 10.4.6.3. Regulatory Framework
      • 10.4.6.4. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.4.7. Denmark
      • 10.4.7.1. Key Country Dynamics
      • 10.4.7.2. Competitive Scenario
      • 10.4.7.3. Regulatory Framework
      • 10.4.7.4. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.4.8. Sweden
      • 10.4.8.1. Key Country Dynamics
      • 10.4.8.2. Competitive Scenario
      • 10.4.8.3. Regulatory Framework
      • 10.4.8.4. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.4.9. Norway
      • 10.4.9.1. Key Country Dynamics
      • 10.4.9.2. Competitive Scenario
      • 10.4.9.3. Regulatory Framework
      • 10.4.9.4. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 10.5. Asia Pacific
    • 10.5.1. Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.5.2. Japan
      • 10.5.2.1. Key Country Dynamics
      • 10.5.2.2. Competitive Scenario
      • 10.5.2.3. Regulatory Framework
      • 10.5.2.4. Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.5.3. China
      • 10.5.3.1. Key Country Dynamics
      • 10.5.3.2. Competitive Scenario
      • 10.5.3.3. Regulatory Framework
      • 10.5.3.4. China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.5.4. India
      • 10.5.4.1. Key Country Dynamics
      • 10.5.4.2. Competitive Scenario
      • 10.5.4.3. Regulatory Framework
      • 10.5.4.4. India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.5.5. Thailand
      • 10.5.5.1. Key Country Dynamics
      • 10.5.5.2. Competitive Scenario
      • 10.5.5.3. Regulatory Framework
      • 10.5.5.4. Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.5.6. South Korea
      • 10.5.6.1. Key Country Dynamics
      • 10.5.6.2. Competitive Scenario
      • 10.5.6.3. Regulatory Framework
      • 10.5.6.4. South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.5.7. Australia
      • 10.5.7.1. Key Country Dynamics
      • 10.5.7.2. Competitive Scenario
      • 10.5.7.3. Regulatory Framework
      • 10.5.7.4. Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 10.6. Latin America
    • 10.6.1. Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.6.2. Brazil
      • 10.6.2.1. Key Country Dynamics
      • 10.6.2.2. Competitive Scenario
      • 10.6.2.3. Regulatory Framework
      • 10.6.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.6.3. Argentina
      • 10.6.3.1. Key Country Dynamics
      • 10.6.3.2. Competitive Scenario
      • 10.6.3.3. Regulatory Framework
      • 10.6.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 10.7. MEA
    • 10.7.1. MEA Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.7.2. South Africa
      • 10.7.2.1. Key Country Dynamics
      • 10.7.2.2. Competitive Scenario
      • 10.7.2.3. Regulatory Framework
      • 10.7.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.7.3. Saudi Arabia
      • 10.7.3.1. Key Country Dynamics
      • 10.7.3.2. Competitive Scenario
      • 10.7.3.3. Regulatory Framework
      • 10.7.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.7.4. UAE
      • 10.7.4.1. Key Country Dynamics
      • 10.7.4.2. Competitive Scenario
      • 10.7.4.3. Regulatory Framework
      • 10.7.4.4. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.7.5. Kuwait
      • 10.7.5.1. Key Country Dynamics
      • 10.7.5.2. Competitive Scenario
      • 10.7.5.3. Regulatory Framework
      • 10.7.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)

List of Tables

  • Table 1. List of Tables
  • Table 2. List of Secondary Sources
  • Table 3. List of Abbreviations
  • Table 4. Global Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 5. Global Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 6. Global Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 7. Global Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 8. Global Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 9. Global Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
  • Table 10. Global Neurology Clinical Trials Market Estimates and Forecasts, by Region, 2018 - 2030 (USD Million)
  • Table 11. North America Neurology Clinical Trials Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 12. North America Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 13. North America Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 14. North America Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 15. North America Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 16. North America Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 17. North America Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
  • Table 18. U.S. Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 19. U.S. Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 20. U.S. Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 21. U.S. Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 22. U.S. Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 23. U.S. Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
  • Table 24. Canada Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 25. Canada Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 26. Canada Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 27. Canada Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 28. Canada Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 29. Canada Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
  • Table 30. Mexico Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 31. Mexico Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 32. Mexico Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 33. Mexico Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 34. Mexico Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 35. Mexico Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
  • Table 36. Europe Neurology Clinical Trials Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 37. Europe Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 38. Europe Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 39. Europe Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 40. Europe Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 41. Europe Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 42. Europe Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
  • Table 43. UK Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 44. UK Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 45. UK Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 46. UK Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 47. UK Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 48. UK Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
  • Table 49. Germany Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 50. Germany Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 51. Germany Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 52. Germany Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 53. Germany Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 54. Germany Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
  • Table 55. France Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 56. France Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 57. France Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 58. France Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 59. France Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 60. France Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
  • Table 61. Italy Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 62. Italy Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 63. Italy Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 64. Italy Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 65. Italy Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 66. Italy Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
  • Table 67. Spain Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 68. Spain Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 69. Spain Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 70. Spain Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 71. Spain Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 72. Spain Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
  • Table 73. Denmark Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 74. Denmark Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 75. Denmark Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 76. Denmark Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 77. Denmark Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 78. Denmark Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
  • Table 79. Sweden Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 80. Sweden Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 81. Sweden Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 82. Sweden Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 83. Sweden Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 84. Sweden Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
  • Table 85. Norway Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 86. Norway Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 87. Norway Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 88. Norway Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 89. Norway Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 90. Norway Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
  • Table 91. Asia Pacific Neurology Clinical Trials Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 92. Asia Pacific Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 93. Asia Pacific Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 94. Asia Pacific Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 95. Asia Pacific Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 96. Asia Pacific Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 97. Asia Pacific Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
  • Table 98. Japan Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 99. Japan Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 100. Japan Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 101. Japan Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 102. Japan Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 103. Japan Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
  • Table 104. China Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 105. China Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 106. China Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 107. China Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 108. China Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 109. China Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
  • Table 110. India Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 111. India Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 112. India Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 113. India Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 114. India Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 115. India Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
  • Table 116. Thailand Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 117. Thailand Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 118. Thailand Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 119. Thailand Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 120. Thailand Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 121. Thailand Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
  • Table 122. South Korea Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 123. South Korea Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 124. South Korea Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 125. South Korea Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 126. South Korea Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 127. South Korea Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
  • Table 128. Australia Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 129. Australia Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 130. Australia Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 131. Australia Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 132. Australia Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 133. Australia Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
  • Table 134. Latin America Neurology Clinical Trials Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 135. Latin America Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 136. Latin America Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 137. Latin America Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 138. Latin America Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 139. Latin America Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 140. Latin America Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
  • Table 141. Brazil Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 142. Brazil Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 143. Brazil Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 144. Brazil Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 145. Brazil Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 146. Brazil Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
  • Table 147. Argentina Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 148. Argentina Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 149. Argentina Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 150. Argentina Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 151. Argentina Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 152. Argentina Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
  • Table 153. Middle East & Africa Neurology Clinical Trials Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 154. Middle East & Africa Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 155. Middle East & Africa Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 156. Middle East & Africa Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 157. Middle East & Africa Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 158. Middle East & Africa Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 159. Middle East & Africa Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
  • Table 160. South Africa Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 161. South Africa Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 162. South Africa Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 163. South Africa Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 164. Saudi Arabia Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 165. Saudi Arabia Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 166. Saudi Arabia Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 167. Saudi Arabia Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 168. Saudi Arabia Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 169. Saudi Arabia Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
  • Table 170. UAE Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 171. UAE Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 172. UAE Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 173. UAE Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 174. UAE Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 175. UAE Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
  • Table 176. Kuwait Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 177. Kuwait Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 178. Kuwait Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 179. Kuwait Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 180. Kuwait Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 181. Kuwait Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Commodity flow analysis
  • Fig. 7 Value-chain-based sizing & forecasting
  • Fig. 8 QFD model sizing & forecasting
  • Fig. 9 Bottom-up approach
  • Fig. 10 Market snapshot
  • Fig. 11 Segment snapshot 1
  • Fig. 12 Segment snapshot 2
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Parent market outlook, 2024 (USD Billion)
  • Fig. 15 Ancillary market outlook, 2024 (USD Billion)
  • Fig. 16 Neurology Clinical Trials Market Dynamics
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Neurology Clinical Trials Market: Phase outlook and key takeaways
  • Fig. 20 Neurology Clinical Trials Market: Phase movement analysis
  • Fig. 21 Phase I Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Phase II Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Phase III Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Phase IV Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Neurology Clinical Trials Market: Study design outlook and key takeaways
  • Fig. 26 Neurology Clinical Trials Market: Study design movement analysis
  • Fig. 27 Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Neurology Clinical Trials Market: Indication outlook and key takeaways
  • Fig. 31 Neurology Clinical Trials Market: Indication movement analysis
  • Fig. 32 Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Depression (MDD) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Parkinson's Disease (PD) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Epilepsy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Stroke Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Traumatic Brain Injury (TBI) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Amyotrophic Lateral Sclerosis (ALS) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Huntington's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Muscle Regeneration Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Neurology Clinical Trials Market: Indication by Study Design outlook and key takeaways
  • Fig. 43 Neurology Clinical Trials Market: Indication by Study Design movement analysis
  • Fig. 44 Alzheimer's Disease Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Alzheimer's Disease Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Alzheimer's Disease Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Depression (MDD) Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Depression (MDD) Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Depression (MDD) Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Parkinson's Disease (PD) Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Parkinson's Disease (PD) Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Parkinson's Disease (PD) Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Epilepsy Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Epilepsy Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Epilepsy Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Stroke Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Stroke Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Stroke Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Traumatic Brain Injury (TBI) Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Traumatic Brain Injury (TBI) Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Traumatic Brain Injury (TBI) Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Amyotrophic Lateral Sclerosis (ALS) Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Amyotrophic Lateral Sclerosis (ALS) Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Amyotrophic Lateral Sclerosis (ALS) Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Huntington's Disease Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Huntington's Disease Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Huntington's Disease Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Muscle Regeneration Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Muscle Regeneration Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Muscle Regeneration Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Others Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Others Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Others Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Neurology Clinical Trials Market: Value Chain Design outlook and key takeaways
  • Fig. 75 Neurology Clinical Trials Market: Value Chain movement analysis
  • Fig. 76 In-house Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 CROs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Investigator Sites/Clinical Sites Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Regional Marketplace: Key Takeaways
  • Fig. 80 North America Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 U.S. Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 Canada Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Mexico Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Europe Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 UK Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 Germany Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 France Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 94 Key country dynamics
  • Fig. 95 Italy Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 96 Key country dynamics
  • Fig. 97 Spain Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 98 Key country dynamics
  • Fig. 99 Denmark Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 100 Key country dynamics
  • Fig. 101 Sweden Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 102 Key country dynamics
  • Fig. 103 Norway Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 104 Asia Pacific Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 105 Key country dynamics
  • Fig. 106 Japan Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 107 Key country dynamics
  • Fig. 108 China Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 109 Key country dynamics
  • Fig. 110 India Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 111 Key country dynamics
  • Fig. 112 Thailand Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 113 Key country dynamics
  • Fig. 114 South Korea Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 115 Key country dynamics
  • Fig. 116 Australia Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 117 Latin America Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 118 Key country dynamics
  • Fig. 119 Brazil Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 120 Key country dynamics
  • Fig. 121 Argentina Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 122 MEA Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 123 Key country dynamics
  • Fig. 124 South Africa Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 125 Key country dynamics
  • Fig. 126 Saudi Arabia Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 127 Key country dynamics
  • Fig. 128 UAE Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 129 Key country dynamics
  • Fig. 130 Kuwait Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 131 Key company categorization
  • Fig. 132 Service heat map analysis
  • Fig. 133 Strategic framework